Quebec extends free drug coverage to 300 000

Pindera, Loreen
March 2007
CMAJ: Canadian Medical Association Journal;3/27/2007, Vol. 176 Issue 7, p917
Academic Journal
The article reports on an initiative undertaken by the Quebec Ministry of Health and Social Services to extend free drug coverage to 300,000 citizens, including the seniors, those with limited income and citizens on welfare programs. The initiative was announced on February 1, 2007 together with a plan to lift the freeze on prescription drug prices. Project Genesis community organizer, Aaron Lakoff, believes the initiative is a significant improvement to the drug plan.


Related Articles

  • Pharmacy to CMS: Medicaid rule is recipe for disaster. Paul, Reid // Drug Topics;1/22/2007, Vol. 151 Issue 2, p34 

    The article focuses on the proposed rule of the Centers for Medicare & Medicaid Services under the provisions of the Deficit Reduction Act of 2005 (DRA) concerning the five-year period Medicaid generic drug reimbursement. The DRA covers the modification of the formula for calculating federal...

  • Quebec reports C. difficile mortality statistics. Eggertson, Laura // CMAJ: Canadian Medical Association Journal;7/19/2005, Vol. 173 Issue 2, p139 

    Focuses on the third surveillance report on Clostridium difficile, released by the Ministry of Health of Quebec in June 2005. Total number of deaths caused by Clostridium difficile from August to December 2004; Mortality rate of Clostridium difficile cases; Percentage decline in Clostridium...

  • Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs. Bach, Peter B. // New England Journal of Medicine;2/5/2009, Vol. 360 Issue 6, p626 

    The article examines the reasons for increases in cancer-drug prices and spending. It focuses on the U.S. social insurance program Medicare and the legislative and regulatory framework that shields cancer drugs from strategies to keep the prices down. Medicare's strategies including control of...

  • Physician allocation system in Quebec inhibits recruitment. Hoag, Hannah // CMAJ: Canadian Medical Association Journal;1/6/2009, Vol. 180 Issue 1, p25 

    The article focuses on the physician allocation system in Quebec Province. It states that a citizen's committee in the province is calling for a change to the way doctors are allocated within the province. It discusses the insights of Dr. Robert Pincott regarding the issues on the existing...

  • Healthcare update. Scott, Lisa // Modern Healthcare;6/20/94, Vol. 24 Issue 25, p18 

    Discusses the debate over discounted drug prices. Proposed health care reform's call for drug companies to offer the same prices to buyers that meet the same terms; Inability to serve Medicare patients under the proposed outpatient drug benefit; Perception of hospitals and health maintenance...

  • Watchdog set to reject four kidney cancer drugs for NHS. O'Dowd, Adrian // BMJ: British Medical Journal (International Edition);8/16/2008, Vol. 337 Issue 7666, p371 

    The article reports on a decision from Great Britain's National Institute for Health and Clinical Excellence to consider not allowing the country's National Health Service to offer the drugs sunitib, bevacizumab, sorafenib and temsirolimus to patients with advanced renal cancer. The institute...

  • Australia's PBPA to cease operations.  // PharmacoEconomics & Outcomes News;Mar2014, Vol. 698 Issue 1, p10 

    The article reports on the Australian government's streamlined process to improve access to medicines and reduce the time taken list medicines on the Pharmaceutical Benefits Scheme (PBS), with the Pharmaceutical Benefits Pricing Authority (PBPA) to stop operation starting April 1, 2014.

  • The Great Pharmacy Rip-off. Ragg, Mark // Bulletin with Newsweek;12/08/98, Vol. 117 Issue 6152, p26 

    Presents information on the deal between the Australian government under Hawke and the Pharmacy Guild over the price charged to the public for prescription drugs. The government and the pharmacists agreeing that the public should pay more; Secrecy about the agreement; Details on the various...

  • A new substitute for breakthrough Rx council passes Senate panel. Conlan, Michael F. // Drug Topics;6/27/94, Vol. 138 Issue 12, p74 

    Cites a federal health policy agency study that would replace President Bill Clinton's proposed advisory council on breakthrough drug prices under healthcare reform legislation approved by the Senate Labor & Human Resources Committee. Agency for Health Care Policy & Assessment's examination of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics